This is a delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Fraunhofer USA, Inc. for $1,969,307.00 to establish a Nicotiana benthamiana expression system for three anti-Ebola virus monoclonal antibodies. The task order was issued under the Defense Advanced Research Projects Agency (DARPA) Plant Based Proteins Development and Manufacture contract vehicle. The award does not have a set-aside designation and the work is to be...
<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Boston Bioscience Inc. on September 27, 2012. The contract, valued at $35,705.00, is for the delivery of EBOLA GP (Z) CARBOXYL TERMINUS ACID PEPTIDES, 15 AMINO ACIDS IN LENGTH. The contract has a completion date of October 3, 2012 and does not utilize a set-aside designation.</p>
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Ebioscience, Inc., a subsidiary of Affymetrix, Inc. The contract is for the delivery of antibodies with a ceiling value of $4,825.50. The award was made on July 21, 2014, with a completion date of July 25, 2014. The contract was not set aside for any specific business type. This award appears to be part of NIAID's broader efforts to procure various reagents and supplies for...
The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,657.20 firm fixed-price purchase order to Ebioscience, Inc., a subsidiary of Affymetrix, Inc., for the supply of monoclonal antibodies, including shipping charges. The contract, which does not have a set-aside designation, was awarded on September 11, 2011, with a completion date of September 19, 2012. This standing order is likely part of NIAID's broader efforts to...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), to Plant Vax, Inc., a woman-owned small business. The objective of the $288,224 Firm Fixed Price contract is to overcome toxicity and increase expression of recombinant HIV SOSIP envelope by co-transfection with endoplasmic reticulum (ER) chaperones using a plant expression system. This work is part of the...
<p>This is a firm-fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Alpha Diagnostic International Inc., a woman-owned small business. The order is for the procurement of 12 bulk kits of the AMBIS # 1774444 Human Anti-Zaire Ebola Virus Glycoprotein (GP) IgG ELISA Kit, 96 tests quantitative. The total ceiling value of the award is $69,910.00, with a completion date of June 16, 2016. This award does not have a set-aside designation.</p>
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a subcomponent of the U.S. Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the provision of a human anti-Zaire Ebola virus glycoprotein (GP) IgG ELISA kit and low NSB diluent bottle. The contract has a ceiling value of $82,765.00 and a performance period ending on May 1,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
This $2,306,148 federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Battelle Memorial Institute to support an efficacy study of a monoclonal antibody (MAb) therapeutic against the Ebola virus (EBOV) lethal challenge in rhesus macaques. The contract is a Delivery Order issued under Battelle's BARDA Biological Animal Model Development 2017-2022 Indefinite Delivery/Indefinite Quantity (IDIQ)...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to EBioscience, Inc., a subsidiary of Affymetrix, Inc. The contract is for the supply of 500 milligrams of a CD 4 functional grade depletion antibody, with a ceiling value of $15,000.00. The contract was awarded on September 18, 2013, with an ultimate completion date of October 2, 2013. The contract was set aside for...